DSGN vs PTC · $214.0M cap vs P/E 48, rev $2.74B
Design Therapeutics Inc (DSGN) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported DSGN revenue for 2026-06-30 was $0. Net income was -$37.8M. DSGN currently screens at market cap $214.0M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
DSGN currently screens at market cap $214.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the DSGN and PTC stock pages for the full models.
Not investment advice.